Medical cannabis opportunity gathers momentum in Europe.

Medical cannabis opportunity gathers momentum in Europe

Witnessing massive growth in North America, markets in Europe and the UK are welcoming the inflow of the so-called “pot stocks” — listed companies in the cannabis industry. There is particular attention to projects focusing on cannabis-based healthcare products, as more countries relax medical cannabis regulations.

Reports from Bloomberg evidence that cannabis medical companies have started contacting lawyers and investment firms, showing significant interest in listing in European markets, including the UK. In November 2018, the UK government gave the go-ahead for specialist doctors to start prescribing cannabis-based medicines. The move prompted the opening of the UK’s first cannabis clinic in the Greater Manchester area earlier in March, offering treatments for patients suffering from chronic pain and other severe neurological or psychiatric conditions.

Research from Prohibition Partners and the Davos World Economic Forum pointed that Europe’s medical cannabis market could double in size in 2019, and numbers show that Europe’s cannabis market could be worth up to €123bn by 2028.

The market excitement follows a wave of regulations that are allowing the advance of legal cannabis across the continent. Last year, apart from the UK, Portugal and Malta had also legalised medical cannabis products.

At the moment, the most prominent marijuana company is London’s Sativa Investments Plc at about 26.8 million pounds ($33.6 million) on the NEX Exchange, but this scenario is set to change throughout 2019. Newspapers in London have recently reported that Jacana, which grows medical-use cannabis in Jamaica, is considering a stock market float on city’s AIM later this year. Other companies showing plans to list are European Cannabis Holdings and Emmac Life Sciences.

Companies in continental Europe are signalling to make an early move into the cannabis scene, says Bloomberg. Paris-based Gour Medical AG, which plans to produce medical cannabis products for animals; StenoCare A/S from Denmark and Dermapharm Holding SE from Germany both focusing on medical and pharmaceutical cannabis applications.

Indeed, there is an opportunity in there: in Germany, around 40,000 patients are already taking prescription drugs based on cannabis, which amounted to more than 30 Million EUR revenues in the first half of 2018 — making the country feature among the three largest medical cannabis markets in Europe, along with the Netherlands and Italy.

Vertbase: Coinbase for Altcoins.

Accelerating cryptocurrency adoption

Founded in 2018, Vertbase is a highly secure and user-friendly digital currency platform for buying and selling cryptocurrencies with US Dollars. Vertbase was born with the aim of finding a solution to the complex, time-consuming and expensive process of trading altcoins on most crypto exchanges, which tends to prevent non-experts from engaging in crypto trading.

Coinbase is a great platform for only few cryptocurrencies, but there are many other coins with high value that cannot be traded on the Coinbase exchange.

Looking at Coinbase and the challenge around coin trading, Justin Seidl and Stuart Menzies, co-founder at Vertabse, created a digital altcoin trading platform that is user-friendly, super-fast and highly secure. A Coinbase for altcoins, but only the one with legitimate projects and strong use cases, particularly those Vertbase believes can change the landscape of finance: DigiByte, Vertcoin, Bitcoin, Litecoin, Ravencoin and Decred.

In the latest episode of FinancialFox, Justin Seidl was interviewed by Blockchain PR expert Stefania Barbaglio, where he talked about how he came to create and design Vertbase, and shares his views on the altcoins to watch.

The mission behind Vertbase is to give visibility and market exposure to altcoins with high use case value. Altcoins are considerably less expensive than coins such as Bitcoin and Ethereum, and in some cases are more sophisticated and highly developed.

Over the recent months, cryptocurrency exchanges have been in the spotlight over coins being delisted and alleged extortionate listing fees required by prominent exchanges. These controversies highlighted the need for corrections in the way the crypto market works and the challenges that need to be overcome. They also prompted more calls for further decentralisation and transparency among exchanges.

Indeed, the current lack of regulatory frameworks leaves room for inconsistent practices. Different cryptocurrency exchanges can offer various types of cryptocurrencies, with different terms, policies, payment methods, and fees. Exchanges also differ on aspects such as security, user-friendliness, functionality, and design.

Some of the advantages Vertbase offers users is 100% non-custodial transactions that allow users to send coins to any wallet of their choice. In the spirit of co-operation, Vertbase also gives a portion of trading fees back to the community to continue development.

Moreover, with security reportedly the biggest worry among cryptocurrency traders, Vertbase is equipped with a robust anti-money laundering monitoring system. Furthermore, its system requires two-factor authentication, granting access to authorised users only, while the website and apps are fully secured with 128-bit encryption. Vertbase is registered with FinCEN and operates with full compliance and procedures under all US federal and state laws.

This January, Vertbase donated 50,000 DGB to the DigiByte Awareness Team to show their support of the project and DigiByte’s vision. “DigiByte has proven strong use cases, which include security features utilising the Digibyte Blockchain. Digibyte has some exciting plans and projects, so we have no doubt they will continue to be a major player in this industry,” says co-founder Justin Seidl.

Vertbase Founders Justin Seidl and Stuart Menzies will also be presenting at the DBG summit. The DGB community can also expect more news and updates on DGB projects to be released during the first global DigiByte Summit, taking place in Amsterdam on 19th April 2019. The theme of the Summit is ‘The Power of Decentralisation’ and its agenda will expand on the multitude of possibilities and uses enabled by decentralised technologies.

Tickets can be purchased here: http://digibytesummit.io

Markets start to welcome cannabis projects as regulations soften around the world

As more countries become more open-minded in adopting the use of cannabis for multiple applications, particularly medical treatment, markets in North America and Europe are witnessing an unprecedented inflow of companies and projects working with hemp products.

Cannabis-derived plants can offer a multitude of uses. Hemp, a ‘softer’ plant of the cannabis species, is a very useful crop that can be turned into everything from clothes to shoes, paper, animal feed and building insulation.

But the current cannabis market craze is largely focused on the area of medical and healthcare products. Cannabis-related products are used for preventing Alzheimer’s, decreasing anxiety symptoms, treating effects of autism and epilepsy, relieving arthritis, reducing nausea and even helping prevent cancer.

According to data compiled by Mordor Intelligence, the global cannabis market was valued at USD 7.7 Billion in 2016 and is expected to reach USD 65 Billion by 2023.

Sales of hemp products in the US reached $1bn (£760m) in 2018, according to New Frontier Data, with the US having legalised the cultivation of hemp across the US just before Christmas ̶ welcome news for farmers.

Furthermore, the data from New Frontier shows forecasts for US sales of hemp products reaching $2.6bn by 2022. At the same time, it predicts global hemp industry sales to jump to $5.7bn by 2020 — from $3.7bn in 2018.

The hype is indeed real, so much so that a university in the US is now offering a degree in Marijuana studies, within its Chemistry school.

A success story: Canada

The flagship of cannabis market prosperity is Canada. The country legalised recreational cannabis use in October last year and since, the market has witnessed impressive growth and companies moving towards the sector.

Just a couple weeks ago, the FT reported that the Horizons Marijuana Life Sciences Index fund has grown to $1.3bn in assets, making the world’s first cannabis exchange traded fund set to become the second most profitable ETF in Canada, after returning more than 50 per cent so far this year.

Canada is also home to the leader in the global cannabis industry, Canopy Growth Corp., with a market value north of $16 billion.

Carol Pepper, advisor at Pepper International, told CNBC that legalisation of pot in Canada had “blown through expectations”. The numbers impressed investors and bankers around the world, which seem to inspire a European wave of openness towards cannabis projects.

Market Opportunity in Europe and the UK

In light of the massive growth in Canada, markets in Europe and the UK are welcoming the inflow of so-called “pot stocks”. According to Bloomberg, cannabis medical companies have shown significant interest in listing in European markets, including the UK.

In the region, the medicinal cannabis market in 2028 will be valued at Euro 55 billion, with the recreational cannabis market worth 60 billion Euros across both primary and secondary services to the cannabis industry, assuming that all European countries have passed legislation by 2023.

In November 2018, the UK government gave the go-ahead for specialist doctors to start prescribing cannabis-based medicines. This led to the opening of the UK’s first cannabis clinic in the Greater Manchester area earlier in March, offering treatments for patients suffering from chronic pain and other serious neurological or psychiatric conditions.

If cannabis stocks are ̶ for the moment ̶ a niche market, loosening in regulation in the UK has been seen as positive for the markets and offers the chance for pot stocks to go mainstream.

At the moment, the biggest marijuana company is London’s Sativa Investments Plc at about 26.8 million pounds ($33.6 million) on the NEX Exchange, but this scenario is set to change throughout 2019.

It has recently been reported that Jacana, which grows medical-use cannabis in Jamaica, is considering a stock market float on AIM later this year. The company raised $20m (£15.08m) in private investment in 2018.

Other companies showing plans to list are European Cannabis Holdings, responsible for helping in the arrival of the first legal shipment of marijuana in Britain earlier this year, and Emmac Life Sciences.

Nick Davis, chief executive of law firm Memery Crystal, which is advising cannabis companies to enter the London market, said to This is Money that there are many companies targeting both the main market and the AIM.

‘I think this will be the year that there are a significant number of listings — though it’s predicated on no change to regulation here. ‘I’d be surprised if there weren’t a dozen companies across AIM and the main market by the year-end,’ he commented.

Bloomberg also hints at other European companies that are signalling to make an early move into the cannabis scene: Paris-based Gour Medical AG, which plans to produce medical cannabis products for animals; StenoCare A/S from Denmark and Dermapharm Holding SE from Germany both focusing on medical and pharmaceutical cannabis applications.

Markets start to welcome cannabis projects as regulations soften around the world

As more countries become more open-minded in adopting the use of cannabis for multiple applications, particularly medical treatment, markets in North America and Europe are witnessing an unprecedented inflow of companies and projects working with hemp products.

Cannabis-derived plants can offer a multitude of uses. Hemp, a ‘softer’ plant of the cannabis species, is a very useful crop that can be turned into everything from clothes to shoes, paper, animal feed and building insulation.

But the current cannabis market craze is largely focused on the area of medical and healthcare products. Cannabis-related products are used for preventing Alzheimer’s, decreasing anxiety symptoms, treating effects of autism and epilepsy, relieving arthritis, reducing nausea and even helping prevent cancer.

According to data compiled by Mordor Intelligence, the global cannabis market was valued at USD 7.7 Billion in 2016 and is expected to reach USD 65 Billion by 2023.

Sales of hemp products in the US reached $1bn (£760m) in 2018, according to New Frontier Data, with the US having legalised the cultivation of hemp across the US just before Christmas ̶ welcome news for farmers.

Furthermore, the data from New Frontier shows forecasts for US sales of hemp products reaching $2.6bn by 2022. At the same time, it predicts global hemp industry sales to jump to $5.7bn by 2020 — from $3.7bn in 2018.

The hype is indeed real, so much so that a university in the US is now offering a degree in Marijuana studies, within its Chemistry school.

A success story: Canada

The flagship of cannabis market prosperity is Canada. The country legalised recreational cannabis use in October last year and since, the market has witnessed impressive growth and companies moving towards the sector.

Just a couple weeks ago, the FT reported that the Horizons Marijuana Life Sciences Index fund has grown to $1.3bn in assets, making the world’s first cannabis exchange traded fund set to become the second most profitable ETF in Canada, after returning more than 50 per cent so far this year.

Canada is also home to the leader in the global cannabis industry, Canopy Growth Corp., with a market value north of $16 billion.

Carol Pepper, advisor at Pepper International, told CNBC that legalisation of pot in Canada had “blown through expectations”. The numbers impressed investors and bankers around the world, which seem to inspire a European wave of openness towards cannabis projects.

Market Opportunity in Europe and the UK

In light of the massive growth in Canada, markets in Europe and the UK are welcoming the inflow of so-called “pot stocks”. According to Bloomberg, cannabis medical companies have shown significant interest in listing in European markets, including the UK.

In the region, the medicinal cannabis market in 2028 will be valued at Euro 55 billion, with the recreational cannabis market worth 60 billion Euros across both primary and secondary services to the cannabis industry, assuming that all European countries have passed legislation by 2023.

In November 2018, the UK government gave the go-ahead for specialist doctors to start prescribing cannabis-based medicines. This led to the opening of the UK’s first cannabis clinic in the Greater Manchester area earlier in March, offering treatments for patients suffering from chronic pain and other serious neurological or psychiatric conditions.

If cannabis stocks are ̶ for the moment ̶ a niche market, loosening in regulation in the UK has been seen as positive for the markets and offers the chance for pot stocks to go mainstream.

At the moment, the biggest marijuana company is London’s Sativa Investments Plc at about 26.8 million pounds ($33.6 million) on the NEX Exchange, but this scenario is set to change throughout 2019.

It has recently been reported that Jacana, which grows medical-use cannabis in Jamaica, is considering a stock market float on AIM later this year. The company raised $20m (£15.08m) in private investment in 2018.

Other companies showing plans to list are European Cannabis Holdings, responsible for helping in the arrival of the first legal shipment of marijuana in Britain earlier this year, and Emmac Life Sciences.

Nick Davis, chief executive of law firm Memery Crystal, which is advising cannabis companies to enter the London market, said to This is Money that there are many companies targeting both the main market and the AIM.

‘I think this will be the year that there are a significant number of listings — though it’s predicated on no change to regulation here. ‘I’d be surprised if there weren’t a dozen companies across AIM and the main market by the year-end,’ he commented.

Bloomberg also hints at other European companies that are signalling to make an early move into the cannabis scene: Paris-based Gour Medical AG, which plans to produce medical cannabis products for animals; StenoCare A/S from Denmark and Dermapharm Holding SE from Germany both focusing on medical and pharmaceutical cannabis applications.

Markets start to welcome cannabis projects as regulations soften around the world

As more countries become more open-minded in adopting the use of cannabis for multiple applications, particularly medical treatment, markets in North America and Europe are witnessing an unprecedented inflow of companies and projects working with hemp products.

Cannabis-derived plants can offer a multitude of uses. Hemp, a ‘softer’ plant of the cannabis species, is a very useful crop that can be turned into everything from clothes to shoes, paper, animal feed and building insulation.

But the current cannabis market craze is largely focused on the area of medical and healthcare products. Cannabis-related products are used for preventing Alzheimer’s, decreasing anxiety symptoms, treating effects of autism and epilepsy, relieving arthritis, reducing nausea and even helping prevent cancer.

According to data compiled by Mordor Intelligence, the global cannabis market was valued at USD 7.7 Billion in 2016 and is expected to reach USD 65 Billion by 2023.

Sales of hemp products in the US reached $1bn (£760m) in 2018, according to New Frontier Data, with the US having legalised the cultivation of hemp across the US just before Christmas ̶ welcome news for farmers.

Furthermore, the data from New Frontier shows forecasts for US sales of hemp products reaching $2.6bn by 2022. At the same time, it predicts global hemp industry sales to jump to $5.7bn by 2020 — from $3.7bn in 2018.

The hype is indeed real, so much so that a university in the US is now offering a degree in Marijuana studies, within its Chemistry school.

A success story: Canada

The flagship of cannabis market prosperity is Canada. The country legalised recreational cannabis use in October last year and since, the market has witnessed impressive growth and companies moving towards the sector.

Just a couple weeks ago, the FT reported that the Horizons Marijuana Life Sciences Index fund has grown to $1.3bn in assets, making the world’s first cannabis exchange traded fund set to become the second most profitable ETF in Canada, after returning more than 50 per cent so far this year.

Canada is also home to the leader in the global cannabis industry, Canopy Growth Corp., with a market value north of $16 billion.

Carol Pepper, advisor at Pepper International, told CNBC that legalisation of pot in Canada had “blown through expectations”. The numbers impressed investors and bankers around the world, which seem to inspire a European wave of openness towards cannabis projects.

Market Opportunity in Europe and the UK

In light of the massive growth in Canada, markets in Europe and the UK are welcoming the inflow of so-called “pot stocks”. According to Bloomberg, cannabis medical companies have shown significant interest in listing in European markets, including the UK.

In the region, the medicinal cannabis market in 2028 will be valued at Euro 55 billion, with the recreational cannabis market worth 60 billion Euros across both primary and secondary services to the cannabis industry, assuming that all European countries have passed legislation by 2023.

In November 2018, the UK government gave the go-ahead for specialist doctors to start prescribing cannabis-based medicines. This led to the opening of the UK’s first cannabis clinic in the Greater Manchester area earlier in March, offering treatments for patients suffering from chronic pain and other serious neurological or psychiatric conditions.

If cannabis stocks are ̶ for the moment ̶ a niche market, loosening in regulation in the UK has been seen as positive for the markets and offers the chance for pot stocks to go mainstream.

At the moment, the biggest marijuana company is London’s Sativa Investments Plc at about 26.8 million pounds ($33.6 million) on the NEX Exchange, but this scenario is set to change throughout 2019.

It has recently been reported that Jacana, which grows medical-use cannabis in Jamaica, is considering a stock market float on AIM later this year. The company raised $20m (£15.08m) in private investment in 2018.

Other companies showing plans to list are European Cannabis Holdings, responsible for helping in the arrival of the first legal shipment of marijuana in Britain earlier this year, and Emmac Life Sciences.

Nick Davis, chief executive of law firm Memery Crystal, which is advising cannabis companies to enter the London market, said to This is Money that there are many companies targeting both the main market and the AIM.

‘I think this will be the year that there are a significant number of listings — though it’s predicated on no change to regulation here. ‘I’d be surprised if there weren’t a dozen companies across AIM and the main market by the year-end,’ he commented.

Bloomberg also hints at other European companies that are signalling to make an early move into the cannabis scene: Paris-based Gour Medical AG, which plans to produce medical cannabis products for animals; StenoCare A/S from Denmark and Dermapharm Holding SE from Germany both focusing on medical and pharmaceutical cannabis applications.

Block 30 Labs: Powering DigiByte to build Digital Asset Indexes

Announced as a speaker at the first DigiByte Global Summit next month, Block 30 Labs is at the forefront of bringing tokenised asset trading to a mass scale, collaborating with DigiByte blockchain.

With its headquarters in San Diego, at the heart California’s tech hub, Block 30 Labs is developing tools to enable digital asset indexes in the blockchain era. The team is a network of global blockchain technologists, computer scientists, economists, financial engineers, researchers and global media alumni from Yale, Harvard, Georgetown, Wharton, Duke, Stanford, UCSB and UCLA — all gathered to develop top-notch financial and trading platforms built on blockchain.

Block 30 Labs is developing three core applications of decentralised blockchain technology for global adoption by consumers, merchants and the Fortune 500 enterprises for release in their 2019–2020 roadmap.

To kick off the project, Block 30 team studied the Alibaba platform and its success in the Chinese market. Block 30 CEO Brian McLaren Foote says the team drew inspiration from the way Alibaba streamlined new technology to create an innovative and efficient consumer experience.

The Chinese giant is indeed one of the most pertinent references in terms of e-commerce, digital payments and interoperability — and Block 30 hopes to replicate this comprehensive and innovative approach for the digital assets market.

Blockchain & E-commerce

The speed and convenience of mobile as a shopping and payment gateway keeps attracting more and more users each year. The use of blockchain technology in ecommerce and digital payments can bring these services to the next level in an already very profitable market: recent data shows that worldwide mobile payment revenue should exceed $1 trillion in 2019 and more than 2.1B consumers are expected to use mobile payments this year. The degree to which online and mobile sales are growing shows the importance of developing a marketplace capable of dealing of tons of data in a commercially viable manner.

The Alibaba Group, Block 30’s role model, is reportedly studying the implementation of blockchain technology into cross-border supply chains. The group already deploys blockchain for other functionalities in their platforms, as well as Internet of Things (IoT).

The main problems in ecommerce nowadays are related to payments checkouts, cybersecurity and supply chain management. By putting an end to intermediary bodies, blockchain can transform ecommerce into a much faster and safer process.

The advantage of using blockchain in ecommerce is the integration and ownership of digital assets — challenging traditional monopolies and protecting users. For example, retailers can launch ICOs directly on the platform and distribute tokens among their customer base. Credit card brands like MasterCard are reportedly working with blockchain to make its market payment systems more fit for use.

The Block 30 index helps to accurately measure the value and performance of digital assets. It is one of the very first US indexes to help investors track multiple factors in the market beyond Bitcoin. With a growing number of Security Token Offerings (STOs) in 2019, the market requires increasingly sophisticated tools to assess the real value of digital assets.

“We hope that the BLOCK 30 Index can help improve industry coverage “Beyond Bitcoin” via global media, government, research and regulatory institutions — while also providing better safeguards and clarity for retail investors seeking early exposure to the front-end of a potential economic cycle,” says Brian Foote.

Block 30 Labs is working on three projects:

1. The BLOCK 30 Marketplace: the world’s first Web 3.0 marketplace built on blockchain. The platform will pair global buyers and sellers for exchanges of value on the blockchain, including: concert tickets, automotive, hospitality, businesses, land, farms, wineries, fractional ownership, mixed use development and commercial real estate.

2. The BLOCK 30 Pay Digital Wallet, which will be available at checkout on the BLOCK 30 Marketplace to help global customers and merchants begin to adopt and use digital assets vs. credit cards through an asset called BLOCKS, powered by DigiByte.

3. The BLOCK 30 Financial Division, which will provide BLOCK 30 Pay digital wallet holders the ability to invest in customised security tokens (ex: BLOCK 5, BLOCK 10, BLOCK 30, etc.) directly from their mobile phone.

In the Web 3.0, the internet will come back into the hands of its users, thanks to decentralisation and distributed consensus protocols. The new model emphasises sharing and collaborating among users in order to concentrate data and operability in the hands of a few companies — known nowadays as ‘big tech’.

But, in order to function in the Web 3.0, blockchain platforms will need to address interoperability — a feature Block 30 Labs is priming. Being interoperable means that a specific blockchain network is able to recognise and operate with others. Without this, blockchain nodes are isolated from those outside, secluded in their own network.

The aim is to allow different blockchain projects to communicate with one another, regardless of their structures, offering more possibilities for users and greater versatility for different projects to be integrated.

Block 30 platforms are built on DigiByte blockchain, which is the longest and fastest blockchain currently available in the crypto market. Despite not being among the most prominent cryptocurrencies, DigiByte holds the potential to be so much more than a digital currency, particularly because of DigiAssets.

For over 2 years, the DigiByte team has been working on this feature that allows other organisations to build their projects on top of DigiByte. DigiByte was designed to scale on-chain, hence maintaining its core aspects of security and decentralisation. Partnerships and collaborations on new projects to change the way people transact and communicate are absolutely vital to the development and wider adoption of DigiByte.

The full digital asset marketplace addresses sectors beyond just store of wealth, such as supply chain management, financial services, social networks, data security, digital identity, gaming, mediums of exchange and privacy. A true representative and comprehensive index should enable exposure to all major thematic sectors, rather than just a small selection, and begin to mirror some of the key sectors that drive global capital markets indexes. In light of this, DigiByte’s DigiAssets were presented as the perfect fit to develop Block 30.

Rudy Bouwman from the DigiByte Awareness Team believes the partnership is extremely positive for DigiByte and goes to show the versatility and user value of DigiAssets: “We’re very excited about the collaboration between DigiByte and Block 30 Labs. Their solutions and services are built on DigiByte Technology and DigiAssets platform, and with that they would be able to position DigiByte in front of consumers, investors, merchants and companies, even Fortune 500. We believe this can drive DigiByte up the ranks significantly in terms of market cap, awareness and adoption.”

DigiByte founder Jared Tate believes Block 30 is a huge step towards eventual mass adoption of DGB technology: “By leveraging the speed, scalability and security of the DigiByte blockchain as the backbone of their offerings, BLOCK 30 Labs will pierce the secondary layers of the consumer, merchant and professional enterprise world, which is a huge milestone along the journey for mass global adoption of the DigiByte ecosystem.”

Stefania Barbaglio, official PR for DigiByte commented: “It is all about collaborating on game-changing projects with good partners. Over the last year DigiByte has proved its potential as forward-thinking blockchain technology with varied partnership on innovative applications and solutions to secure, facilitate, promote faster transactions of assets. Block 30 is a revolutionary team that will accelerate the decentralisation of consumer and enterprise adoption, asset tokenisation and more accessible 1st-3rd world financial cooperation on the blockchain. The e-commerce place is ripe for change and DigiByte and Block30 team are initiating this disruption. The DigiByte team and community are extremely excited about their future announcements at the conference.”

Brian Foote joins a group of high-calibre speakers presenting at the Summit discussing how a future powered by decentralised technologies and Digibyte will look. Confirmed speakers include DigiByte founder Jared Tate; Official DigiByte PR Stefania Barbaglio; Rudy Bouwman, the founder of DGBAT, the DigiByte Awareness Team; the founders and lead developers of V-ID and Antum ID; and Vertbase Founders, Justin Seidl and Stuart Menzies.

DigiByte Global Summit

April 19th, 2019

De Balie

Kleine-Gartmanplantsoen 10, 1017 RR

Amsterdam, Netherlands

Registration open: http://digibytesummit.io

Block 30 Labs presenting at the DigiByte Global Summit

Cassiopeia Services, official PR for DigiByte, is pleased to announce Block 30 Labs as partner at the first DigiByte Global Summit.

Block 30 Labs is developing indexes to work with strategic global partners to issue tokenised, digital index funds (ECFs). The BLOCK 30 Index was built to provide a central framework for the tracking of the 24/7 Digital Trading (“Crypto”) markets by global media, financial institutions, government and investors.

Officially launched in November 2018, the Block 30 index helps to accurately measure the value and performance of digital assets. It is one of the very first US indices to help investors track multiple factors in the market beyond Bitcoin. With a growing number of Security Token Offerings (STOs), the market requires more comprehensive and sophisticated tools to assess the value of digital assets.

The unique aspect to BLOCK 30 is that it begins to disaggregate Digital Trading assets from their singular classification within this new asset class. It distinguishes between core holdings such as Bitcoin — which may function more as a store of value — and STOs, which will function more like Initial Public Offering (IPOs), with real revenues and fundamentals.

Confirmed speakers at the first DigiByte Global summit include DigiByte founder Jared Tate; Official DigiByte PR Stefania Barbaglio; Rudy Bouwman, the founders of DGBAT, the DigiByte Awareness Team; the founders and lead developers of V-ID and Antum ID; and Vertbase Founders, Justin Seidl and Stuart Menzies.

Stefania Barbaglio, official PR for DigiByte commented: “Block 30 is a revolutionary tool to accelerate the development of tokenised asset trading. The DigiByte team and community are very much open to co-operation with valuable new projects that can help build a more transparent and decentralised financial system, and Block 30 is one of them.”

“The excitement and pace of this new asset class has led to the need to work backwards into traditional fundamentals like market indexes, tokenized index funds and more “one-click” interoperability between customer marketplaces, digital wallets and investment products’, said BLOCK 30 Labs CEO, Brian McLaren Foote.

We’re working at BLOCK 30 Labs to solve that — and having DigiByte and DGB Assets as a strategic technology partners “under the hood” is an enormous win for us on delivering product-market-fit for our clients and exchanges.

“If you look at the core tech + specs of Bitcoin, Litecoin + Ethereum, there are so many features and benefits to the DigiByte offering that are not yet reflected in its market cap and global adoption. Our goal is to help drive that change forward to the benefit of consumers, merchants + Fortune 500 enterprise.”

DigiByte Global Summit

April 19th, 2019

De Balie

Kleine-Gartmanplantsoen 10, 1017 RR

Amsterdam, Netherlands

Tickets can be purchased here: http://digibytesummit.io

Mining transformed by digital revolution and clean energy shift

The mining industry is undergoing a core transformation — from the way operations work to the rising demand for base metals. Propelled by technology, pressing ethical standards and the fourth industrial revolution, the mining sector has been rethinking its approach to business since 2017.

Leveraging on the global energy transition propelled by governments and companies around the world aiming to reduce carbon emissions, as well as demand for metals for use in infrastructure in emerging economies, miners are working to meet the needs of a changing world.

S&P believes copper and zinc will be in the spotlight in the near future. In fact, China’s zinc demand could rise more than predicted in 2019 as infrastructure fixed asset investment growth accelerates to 10% from 3.8% last year, while a pick-up in construction is likely to spur zinc demand and heat up the market, according to Bloomberg Intelligence.

In anticipation of the expanding production of electric vehicles, demand for battery metals is growing, becoming the main opportunity in mining. Demand for lithium is expected to soar, as well as graphite, nickel and copper, confirming the trend for the use of base metals in batteries and storage. Copper is a fundamental metal for electric vehicles, and according to the International Energy Agency, their number will increase 1,389% — to 125 million from three million — by 2030, and 3,333% in 2040 to 300 million.

“Looking back just 20 years, it’d have been hard to believe that nickel, lithium, cobalt and graphite would be an affordable way to power batteries,” says Phil Hopwood, Global Mining Leader at Deloitte. “Today that is the reality and a potential growth opportunity, particularly with the emergence of electric vehicles.”

Hopwood also highlights that in order to succeed in this changing scenario, companies need to think long term when implementing their strategies, by studying trends and market opportunities and embracing digital innovation. “I see mining really making changes in terms of adopting digital technology and innovative thinking,” he added.

The integration of disruptive technologies into operations and risk management can be one of the pivotal points to enhance activity. Artificial Intelligence, AI, has proven very beneficial. Scenario planning enhanced by AI offers a structured way to consider unpredictable futures, equipping executives and engineers with information they can use to make more strategic choices.

Thanks to the power of AI mining, companies can identify ore bodies in greenfield and/or remote areas without access to pre-existing geological data. EARTH AI, for example, uses machine learning to analyse geophysical data to identify unexplored mineralisation opportunities in Australia. Since April 2018, it has discovered 18 new greenfield prospects with significant copper, zinc, lead, and vanadium mineralisation.

Blockchain, another hyped disruptive technology, can offer multiple advantages to mining companies. An ever-growing consumer awareness means that ethical and corporate responsibility has become a central concern for companies. With the use of blockchain, all the steps in natural resources exploration can be recorded and disclosed, holding companies to account.

Blockchain technology has the capacity to store a huge amount of data on an open, secure and accurate platform. A decentralised digital ledger network can record, track, verify and share each and every element of all the assets in one single network, which is open to public access. It can pull together links all along the chain, from raw material providers right up to retailers. Such technology can help fight slavery, child labour and environmental concerns.

In the realm of precious metals, palladium is surging, also promoted by automotive industry demand. For the first time in more than a decade, palladium is rivalling gold in value. The key drive to rising prices is increasing demand combined with long-term constrained supply.

The palladium price reached as high as $1 400/oz in January 2018, making it ‘the most precious of precious metals,” says Mining Review.

In terms of industry revenue, growth will be stable but much less impressive compared with the sharp increase seen in 2017. For the world’s top 40 miners, 2017 was an outstanding year due to the continuing recovery in commodity prices, fuelled by general economic growth, resulting in revenues rising dramatically by 23 per cent.

For 2019 and 2020, S&P Global Ratings expect relatively flat revenues across the upstream and downstream sectors.

Keep an eye out for our upcoming episode on Financial Fox about new trends in mining and the impact on digitisation. Follow us on @cassiopeia_ltd and subscribe to our YouTube channel.

New approach to the mining sector.

St-Georges Eco-Mining Corp. operates as a mineral exploration and production company. The Company explores gold, platinum, palladium, rhodium, copper, cobalt, nickel, and other base metals. St-Georges Eco-Mining develops its projects in Canada and Iceland.

St-Georges is developing new technologies to solve the some of the most common environmental problems in the mining industry. Part of the strategy of the company is to invest and develop technologies that address corporate responsibility issues underlying the mining industry, and by addressing these flaws, will make mining more sustainable and accountable.

The Company controls directly or indirectly, through rights of first refusal, all of the active mineral tenures in Iceland. It also explores for nickel on the Julie Nickel Project & for industrial minerals on Quebec’s North Shore and for lithium and rare metals in Northern Quebec and in the Abitibi region. Headquartered in Montreal, St-Georges’ stock is listed on the CSE under the symbol SX, on the US OTC under the Symbol SXOOF and on the Frankfurt Stock Exchange under the symbol 85G1.

St Georges’ business model is straightforward: the company develops metal processing technologies to be deployed to change the environmental impact of mining operations around the world, while improving the profitability and the financial bottom line of current base metals producers.